Detalhe da pesquisa
1.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34992255
2.
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
BMC Cancer
; 22(1): 537, 2022 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549674
3.
Withholding the Introduction of Anti-Epidermal Growth Factor Receptor: Impact on Outcomes in RAS Wild-Type Metastatic Colorectal Tumors: A Multicenter AGEO Study (the WAIT or ACT Study).
Oncologist
; 25(2): e266-e275, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043796
4.
Implantation of tissue expander prior to irradiation in the era of intensity modulated radiotherapy: impact on the management of patients with pelvic digestive cancers.
Int J Colorectal Dis
; 35(3): 559-564, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853620
5.
Optimisation of chemotherapy prescription and preparation in an ambulatory unit: Validation of the OPTIMA program.
Eur J Cancer Care (Engl)
; 28(3): e13015, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30790365
6.
CA19.9 decrease >15% is a predictor of favourable outcome in patients treated for advanced pancreatic carcinoma: analysis of two independent cohorts.
HPB (Oxford)
; 21(5): 582-588, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30466797
7.
Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Br J Clin Pharmacol
; 83(3): 623-631, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662818
8.
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology
; 90(2): 88-96, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26784946
9.
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.
Support Care Cancer
; 24(3): 1131-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26268784
10.
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.
Lancet Oncol
; 15(3): 305-14, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24556041
11.
Risk factors associated with hypersensitivity reactions to cetuximab: anti-cetuximab IgE detection as screening test.
Future Oncol
; 10(14): 2133-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25471028
12.
Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer.
Dig Liver Dis
; 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38851974
13.
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.
Eur J Cancer
; 195: 113400, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922632
14.
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Netw Open
; 6(9): e2333533, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37721754
15.
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.
Dig Liver Dis
; 54(6): 747-754, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351371
16.
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial.
BMJ
; 377: e068714, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440464
17.
HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological 18F-FDG anal uptake.
EJNMMI Res
; 10(1): 28, 2020 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193623
18.
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27).
Clin Colorectal Cancer
; 19(4): 301-310.e1, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737004
19.
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
J Clin Oncol
; 36(15): 1469-1477, 2018 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29620995
20.
Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach.
Semin Oncol
; 44(1): 13-23, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28395758